Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2021

01-06-2021 | COVID-19 | Research Article

Community pharmacist’s professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists

Authors: Corrado Giua, Giovanni Paoletti, Luigi Minerba, Giacomo Malipiero, Giulio Melone, Enrico Heffler, Assunta Pistone, Enrico Keber, on behalf of SIFAC Group of Clinical Community Pharmacists (SGCP)

Published in: International Journal of Clinical Pharmacy | Issue 3/2021

Login to get access

Abstract

Background Italy has been the first non-Asian country affected by Coronavirus Disease 19 (COVID-19) pandemic. Community pharmacies are essential services authorized to continue their activity during the emergency. To date, a clear image is lacking of the critical issues Italian community pharmacists had to face and of how they responded in their daily work.. Objective To describe procedures and critical logistical-organizational issues encountered by Italian community pharmacists and to collect the main requests reported by patients to pharmacists. Setting A national survey on Italian community pharmacists. Method A cross-sectional survey using a reasoned questionnaire was sent during the pandemic peak to Italian pharmacies, divided in two groups according to the incidence of COVID-19: “Red Zones” and “non-Red Zones”. Main outcome measure Exploring the most frequently adopted measures by the pharmacists. Results 169 community Pharmacists answered the questionnaire. The most frequently adopted measures were the use of gloves, surgical masks and protective barriers at the drug counter. Most implemented services for customers were: booking of prescriptions, delivery of medications and implementation of phone consultations. Overall, the questionnaire highlighted an increase in the number of health-related consultations and requests by customers. In Red Zones, there was a higher use of FFP2 and FFP3 masks by pharmacists, where customers were mainly interested in gaining information about specific classes of medications. Conclusion Community pharmacists adapted to lockdown measures by implementing a number of measures. There was an overall increase in pharmacists’ personal protective equipment in Red Zones possibly linked to increased risk perception.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.CrossRef Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.CrossRef
2.
go back to reference Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.CrossRef Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.CrossRef
4.
go back to reference Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;4:536–44. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;4:536–44.
7.
go back to reference Fong MW, Gao H, Wong JY, Xiao J, Shiu EYC, Ryu S, et al. Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-social distancing measures. Emerg Infect Dis. 2020;5:976–84.CrossRef Fong MW, Gao H, Wong JY, Xiao J, Shiu EYC, Ryu S, et al. Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-social distancing measures. Emerg Infect Dis. 2020;5:976–84.CrossRef
9.
go back to reference Sebastiani G, Massa M, Riboli E. Covid-19 epidemic in Italy: evolution, projections and impact of government measures. Eur J Epidemiol. 2020;4:341–5.CrossRef Sebastiani G, Massa M, Riboli E. Covid-19 epidemic in Italy: evolution, projections and impact of government measures. Eur J Epidemiol. 2020;4:341–5.CrossRef
11.
go back to reference Wang Y, McKee M, Torbica A, Stuckler D. Systematic literature review on the spread of health-related misinformation on social media. Soc Sci Med. 2019;240:112552.CrossRef Wang Y, McKee M, Torbica A, Stuckler D. Systematic literature review on the spread of health-related misinformation on social media. Soc Sci Med. 2019;240:112552.CrossRef
12.
go back to reference Rovetta A, Bhagavathula AS. COVID-19-related web search behaviors and infodemic attitudes in Italy: infodemiological study. JMIR Public Health Surveill. 2020;6(2):e19374.CrossRef Rovetta A, Bhagavathula AS. COVID-19-related web search behaviors and infodemic attitudes in Italy: infodemiological study. JMIR Public Health Surveill. 2020;6(2):e19374.CrossRef
13.
go back to reference Ung COL. Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Soc Adm Pharm. 2020;4:583–6.CrossRef Ung COL. Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Soc Adm Pharm. 2020;4:583–6.CrossRef
15.
go back to reference Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020;13:8.CrossRef Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020;13:8.CrossRef
16.
go back to reference Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Research in Social and Administrative Pharmacy. Elsevier Inc.; 2020. Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Research in Social and Administrative Pharmacy. Elsevier Inc.; 2020.
18.
go back to reference Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Mar 17. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Mar 17.
19.
go back to reference Cabas P, Di Bella S, Giuffrè M, Rizzo M, Trombetta C, Luzzati R, et al. Community pharmacists’ exposure to COVID-19. Res Social Adm Pharm. 2020;S1551–7411(20):30547–57. Cabas P, Di Bella S, Giuffrè M, Rizzo M, Trombetta C, Luzzati R, et al. Community pharmacists’ exposure to COVID-19. Res Social Adm Pharm. 2020;S1551–7411(20):30547–57.
20.
go back to reference Scarpa N, Sghedoni D, Valetto MR. Il nuovo coronavirus SARS-CoV-2 - edizione per i farmacisti. Quesiti Clin. 2020;11(3). Scarpa N, Sghedoni D, Valetto MR. Il nuovo coronavirus SARS-CoV-2 - edizione per i farmacisti. Quesiti Clin. 2020;11(3).
22.
go back to reference Lancet T. COVID-19: fighting panic with information. Lancet. 2020;395(10224):537.CrossRef Lancet T. COVID-19: fighting panic with information. Lancet. 2020;395(10224):537.CrossRef
24.
go back to reference Al-Quteimat OM MSc, BCOP, Amer AM RPh, MSc. SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm. 2020; S1551-7411(20):30238–2. Al-Quteimat OM MSc, BCOP, Amer AM RPh, MSc. SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm. 2020; S1551-7411(20):30238–2.
26.
go back to reference Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information. Int J Clin Pharm. 2020; 1–10. Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information. Int J Clin Pharm. 2020; 1–10.
27.
go back to reference Bahlol M, Dewey RS. Pandemic preparedness of community pharmacies for COVID-19. Res Social Adm Pharm. 2020;S1551–7411(20):30501–5. Bahlol M, Dewey RS. Pandemic preparedness of community pharmacies for COVID-19. Res Social Adm Pharm. 2020;S1551–7411(20):30501–5.
28.
go back to reference Meghana A, Aparna Y, Chandra SM, Sanjeev S. Emergency preparedness and response (EP&R) by pharmacy professionals in India: lessons from the COVID-19 pandemic and the way forward. Res Social Adm Pharm. 2020:S1551-7411(20)30437-X. Meghana A, Aparna Y, Chandra SM, Sanjeev S. Emergency preparedness and response (EP&R) by pharmacy professionals in India: lessons from the COVID-19 pandemic and the way forward. Res Social Adm Pharm. 2020:S1551-7411(20)30437-X.
29.
go back to reference Abdel Jalil M, Alsous MM, Abu Hammour K, Saleh MM, Mousa R, Hammad EA. Role of pharmacists in COVID-19 disease: a Jordanian perspective. Disaster Med Public Health Prep. 2020;1–7. Abdel Jalil M, Alsous MM, Abu Hammour K, Saleh MM, Mousa R, Hammad EA. Role of pharmacists in COVID-19 disease: a Jordanian perspective. Disaster Med Public Health Prep. 2020;1–7.
32.
go back to reference Capuano A, Scavone C, Racagni G, Scaglione F, Italian Society of Pharmacology. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? Pharmacol Res. 2020;157:104849. Capuano A, Scavone C, Racagni G, Scaglione F, Italian Society of Pharmacology. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? Pharmacol Res. 2020;157:104849.
34.
go back to reference Ou HT, Yang YK. Community pharmacists in Taiwan at the frontline against the novel coronavirus pandemic: gatekeepers for the rationing of personal protective equipment. Ann Intern Med. 2020;173(2):149–50.CrossRef Ou HT, Yang YK. Community pharmacists in Taiwan at the frontline against the novel coronavirus pandemic: gatekeepers for the rationing of personal protective equipment. Ann Intern Med. 2020;173(2):149–50.CrossRef
35.
go back to reference Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Soc Adm Pharm. 2020;S1551–7411(20):30284–9. Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Soc Adm Pharm. 2020;S1551–7411(20):30284–9.
36.
go back to reference Carico RR Jr, Sheppard J, Thomas CB. Community pharmacists and communication in the time of COVID-19: applying the health belief model. Res Soc Adm Pharm. 2020;S1551–7411(20):30293–X. Carico RR Jr, Sheppard J, Thomas CB. Community pharmacists and communication in the time of COVID-19: applying the health belief model. Res Soc Adm Pharm. 2020;S1551–7411(20):30293–X.
37.
go back to reference Hasan SS, Kow CS, Zaidi STR. Social distancing and the use of PPE by community pharmacy personnel: does evidence support these measures? Res Social Adm Pharm. 2020;S1551–7411(20):30490–3. Hasan SS, Kow CS, Zaidi STR. Social distancing and the use of PPE by community pharmacy personnel: does evidence support these measures? Res Social Adm Pharm. 2020;S1551–7411(20):30490–3.
Metadata
Title
Community pharmacist’s professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists
Authors
Corrado Giua
Giovanni Paoletti
Luigi Minerba
Giacomo Malipiero
Giulio Melone
Enrico Heffler
Assunta Pistone
Enrico Keber
on behalf of SIFAC Group of Clinical Community Pharmacists (SGCP)
Publication date
01-06-2021
Publisher
Springer International Publishing
Keyword
COVID-19
Published in
International Journal of Clinical Pharmacy / Issue 3/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01228-5

Other articles of this Issue 3/2021

International Journal of Clinical Pharmacy 3/2021 Go to the issue